Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04501445 · ClinicalTrials.gov registry record · NA

Psychological Symptoms and Families of COVID-19 Patients

A NA study of Post Traumatic Stress Disorder and Family Members, sponsored by Rush University Medical Center.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT04501445: Completed NA study of Post Traumatic Stress Disorder and Family Members, sponsored by Rush University Medical Center.

NCT04501445 is a NA study of Post Traumatic Stress Disorder and Family Members that has completed, run by Rush University Medical Center. The registered enrollment target is 90 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04501445, a NA study of Post Traumatic Stress Disorder and Family Members, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

Families of patients in Intensive Care Units (ICUs) are at increased risk for developing psychological symptoms that can last for months after the patient is discharged. These symptoms can have significant impact on both the patient and family member's quality of life. The investigators have found that families of patients admitted to the Rush University Medical Center ICU during to the COVID-19 pandemic were more likely to develop clinically significant psychological symptoms than families of patients admitted prior to the COVID-19 pandemic. The investigators suspect that this finding is due in part to the hospital-wide no visitation policy that altered our standard communication practices and may have prevented families from being active participants in the patient's medical care. The goals of this project are 1) to determine the prevalence of psychological disorders among families of COVID-19 patients after ICU discharge 2) to determine the characteristics of ICU care that were associated with the development of psychological disorders among family members and 3) to pilot a program in which families with psychological disorders after ICU discharge receive therapy from mental health professionals.

Primary Outcome

Score on Impact of Events Scale Revised (IES-R) questionnaire. 22 questions. Score 0-88 with higher scores indicating more stress.

Interventions

  • BEHAVIORAL Written Summary of Rounds

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2020-09-14
Est. Completion 2021-07-31
Phase NA
Rush University Medical Center

320 total trials

What the finished NCT04501445 record still lists

NCT04501445 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (86% lower).

The record links to 3 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Written Summary of Rounds is the first listed.

NCT04501445 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04501445 about?

NCT04501445 is a clinical study titled "Psychological Symptoms and Families of COVID-19 Patients". Families of patients in Intensive Care Units (ICUs) are at increased risk for developing psychological symptoms that can last for months after the patient is discharged. These symptoms can have significant impact on both the patient and family member's quality of life. The investigators have found ...

What is the current status of trial NCT04501445?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2020-09-14. Estimated completion is 2021-07-31.

What conditions does trial NCT04501445 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Family Members, Post Intensive Care Unit Syndrome.

What interventions are being tested in trial NCT04501445?

The interventions under investigation include: Written Summary of Rounds (BEHAVIORAL).

Who is sponsoring clinical trial NCT04501445?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04501445 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04501445's enrollment target sits among peer trials

90 120th of 262 higher than 141 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04501445, the US trial registry maintained by the National Library of Medicine. NCT04501445 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.